Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP878075.RAlULukM6vsWfKYh4a95HC9jX9jbbkjk-T-NAN-wLMNcY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP878075.RAlULukM6vsWfKYh4a95HC9jX9jbbkjk-T-NAN-wLMNcY130_assertion type Assertion NP878075.RAlULukM6vsWfKYh4a95HC9jX9jbbkjk-T-NAN-wLMNcY130_head.
- NP878075.RAlULukM6vsWfKYh4a95HC9jX9jbbkjk-T-NAN-wLMNcY130_assertion description "[We hypothesized that: 1) CD1 expression increases with disease progression to advanced SCC, and 2) AS-cyclin D1 therapy would lead to prolonged tumor regression in a xenograft model of human SCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP878075.RAlULukM6vsWfKYh4a95HC9jX9jbbkjk-T-NAN-wLMNcY130_provenance.
- NP878075.RAlULukM6vsWfKYh4a95HC9jX9jbbkjk-T-NAN-wLMNcY130_assertion evidence source_evidence_literature NP878075.RAlULukM6vsWfKYh4a95HC9jX9jbbkjk-T-NAN-wLMNcY130_provenance.
- NP878075.RAlULukM6vsWfKYh4a95HC9jX9jbbkjk-T-NAN-wLMNcY130_assertion SIO_000772 10690551 NP878075.RAlULukM6vsWfKYh4a95HC9jX9jbbkjk-T-NAN-wLMNcY130_provenance.
- NP878075.RAlULukM6vsWfKYh4a95HC9jX9jbbkjk-T-NAN-wLMNcY130_assertion wasDerivedFrom befree-20140225 NP878075.RAlULukM6vsWfKYh4a95HC9jX9jbbkjk-T-NAN-wLMNcY130_provenance.
- NP878075.RAlULukM6vsWfKYh4a95HC9jX9jbbkjk-T-NAN-wLMNcY130_assertion wasGeneratedBy ECO_0000203 NP878075.RAlULukM6vsWfKYh4a95HC9jX9jbbkjk-T-NAN-wLMNcY130_provenance.